Literature DB >> 9307295

p53 mutations in squamous cell carcinoma of the head and neck predominate in a subgroup of former and present smokers with a low frequency of genetic instability.

T Liloglou1, A G Scholes, D A Spandidos, E D Vaughan, A S Jones, J K Field.   

Abstract

We examined the p53 mutational profile of 65 squamous cell carcinomas of the head and neck (SCCHNs) from patients living in northwest England. Twenty-three p53 mutations were detected in 20 samples (31%). GC-->AT transitions were the predominant type of mutation. The p53 mutational profile of SCCHN tumors was similar to that of non-small cell lung tumors from patients within the same geographical area, supporting the idea of a common model for carcinogenesis in the upper respiratory tract. Statistical analysis showed that the incidence of p53 mutations among present and former smokers was significantly higher than that in nonsmokers (P < 0.02). In addition, p53 mutations were found to predominate in a group of SCCHN patients with low genetic damage, as indicated by the fractional allelic loss value. The above findings suggest an early initiating role for p53 and imply that at least two separate carcinogenic pathways may be involved in the development of SCCHN.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9307295

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Phylogenetic analysis of multiple FISH markers in oral tongue squamous cell carcinoma suggests that a diverse distribution of copy number changes is associated with poor prognosis.

Authors:  Darawalee Wangsa; Salim Akhter Chowdhury; Michael Ryott; E Michael Gertz; Göran Elmberger; Gert Auer; Elisabeth Åvall Lundqvist; Stefan Küffer; Philipp Ströbel; Alejandro A Schäffer; Russell Schwartz; Eva Munck-Wikland; Thomas Ried; Kerstin Heselmeyer-Haddad
Journal:  Int J Cancer       Date:  2015-08-28       Impact factor: 7.396

2.  Genetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screening.

Authors:  A K El-Naggar; L Mao; G Staerkel; M M Coombes; S L Tucker; M A Luna; G L Clayman; S Lippman; H Goepfert
Journal:  J Mol Diagn       Date:  2001-11       Impact factor: 5.568

3.  A nested-PCR-based schizodeme method for identifying Leishmania kinetoplast minicircle classes directly from clinical samples and its application to the study of the epidemiology of Leishmania tropica in Pakistan.

Authors:  H A Noyes; H Reyburn; J W Bailey; D Smith
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

4.  p53 in head and neck cancer: functional consequences and environmental implications of TP53 mutations.

Authors:  Jenni K Peltonen; Henni M Helppi; Paavo Pääkkö; Taina Turpeenniemi-Hujanen; Kirsi H Vähäkangas
Journal:  Head Neck Oncol       Date:  2010-12-15

5.  Decreased endothelin receptor B expression in large primary uveal melanomas is associated with early clinical metastasis and short survival.

Authors:  S L Smith; B E Damato; A G M Scholes; J Nunn; J K Field; J Heighway
Journal:  Br J Cancer       Date:  2002-11-18       Impact factor: 7.640

6.  Analysis of clinicopathological characteristics associated with the outcome of oral squamous cell carcinoma and the establishment of tissue microarrays.

Authors:  Xin Jin; Dongjuan Liu; Xin Zhao; Yu Zhou; Lu Jiang; Jing Li; Xin Zeng; Qianming Chen
Journal:  Oncol Lett       Date:  2016-09-12       Impact factor: 2.967

7.  Selective intra-arterial infusion of rAd-p53 with chemotherapy for advanced oral cancer: a randomized clinical trial.

Authors:  Yi Li; Long-Jiang Li; Li-Juan Wang; Zhuang Zhang; Ning Gao; Chen-Yuan Liang; Yuan-Ding Huang; Bo Han
Journal:  BMC Med       Date:  2014-01-30       Impact factor: 8.775

8.  Human papillomavirus and p53 mutations in head and neck squamous cell carcinoma among Japanese population.

Authors:  Hiromi Maruyama; Toshimichi Yasui; Tomoko Ishikawa-Fujiwara; Eiichi Morii; Yoshifumi Yamamoto; Tadashi Yoshii; Yukinori Takenaka; Susumu Nakahara; Takeshi Todo; Tadashi Hongyo; Hidenori Inohara
Journal:  Cancer Sci       Date:  2014-03-30       Impact factor: 6.716

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.